ETV5 has been described to be involved in the epithelial to mesenchymal
transition (EMT) mainly in cancer. It is known that EMT provokes cytoskeleton
remodeling, improving cellular migratory, and invasive capabilities. Moreover,
overexpression of ETV5 has been correlated to cancer development and this
gene has been implicated in cell proliferation. However, little is known about
the downregulation of ETV5 expression in a pancreatic cell line and the
inverse mesenchymal to epithelial transition (MET). Therefore, we studied the
implications of ETV5 silencing over the phenotype of the insulinoma INS-1
(832/13) cell line and described the MET by partial ETV5
silencing in the INS-1 (832/13) cell line. The downregulation of
ETV5 expression was obtained by using ETV5 siRNA in the
insulinoma rat cell line, INS-1 (832/13). Then, ETV5 knockdown
provoked a MET phenotype observed by crystal violet staining and verified by
immunohistochemistry against E-cadherin. Wound healing assay showed no
migration, and F-actin stain revealed rearrangement of actin microfilaments. In
addition, TGFβ1 and TGFβ3 were downregulated in
the absence of ETV5. ETV5 silencing induces epithelial phenotype
by downregulating TGFβ1 and TGFβ3 in INS-1
(832/13) cell line.